Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Chandy

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Biological Chemistry|April 16, 1998
Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7K Kalman, A Nguyen, J Tseng-Crank, et al.
Biochemical and Biophysical Research Communications|October 30, 1998
Transmission disequilibrium analysis of a triplet repeat within the hKCa3 gene using family trios with schizophreniaT Li, X Hu, K G Chandy, et al.
The Journal of Biological Chemistry|November 26, 1998
ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptideK Kalman, M W Pennington, M D Lanigan, et al.
American Journal of Medical Genetics|July 14, 1999
Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21S E Antonarakis, J L Blouin, V K Lasseter, et al.
Molecular Psychiatry|July 8, 1999
hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21V Dror, E Shamir, S Ghanshani, et al.
Molecular Pharmacology|December 1, 1996
Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activationA Nguyen, J C Kath, D C Hanson, et al.
British Journal of Pharmacology|June 18, 1999
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.
Molecular Psychiatry|July 22, 1998
Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophreniaT Bowen, C A Guy, N Craddock, et al.
Molecular Pharmacology|January 6, 2009
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesM W Pennington, C Beeton, C A Galea, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Biological Chemistry|April 16, 1998
Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7K Kalman, A Nguyen, J Tseng-Crank, et al.
Biochemical and Biophysical Research Communications|October 30, 1998
Transmission disequilibrium analysis of a triplet repeat within the hKCa3 gene using family trios with schizophreniaT Li, X Hu, K G Chandy, et al.
The Journal of Biological Chemistry|November 26, 1998
ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptideK Kalman, M W Pennington, M D Lanigan, et al.
American Journal of Medical Genetics|July 14, 1999
Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21S E Antonarakis, J L Blouin, V K Lasseter, et al.
Molecular Psychiatry|July 8, 1999
hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21V Dror, E Shamir, S Ghanshani, et al.
Molecular Pharmacology|December 1, 1996
Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activationA Nguyen, J C Kath, D C Hanson, et al.
British Journal of Pharmacology|June 18, 1999
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.
Molecular Psychiatry|July 22, 1998
Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophreniaT Bowen, C A Guy, N Craddock, et al.
Molecular Pharmacology|January 6, 2009
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesM W Pennington, C Beeton, C A Galea, et al.
Pageof 8